FDA NDC Directory · JSON-LD · Markdown

Hydralazine Hydrochloride

NDC 50111-397 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA089098
Dosage form / routeTABLET · ORAL
Active ingredientsHYDRALAZINE HYDROCHLORIDE (100 mg/1)
Marketing started19900930
Package count1

External sources

Source: openFDA. Public-domain (CC0).